Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1711636rdf:typepubmed:Citationlld:pubmed
pubmed-article:1711636lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C0234421lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C0019010lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C0079284lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C0232105lld:lifeskim
pubmed-article:1711636lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:1711636pubmed:issue4lld:pubmed
pubmed-article:1711636pubmed:dateCreated1991-7-29lld:pubmed
pubmed-article:1711636pubmed:abstractTextThe effects of endothelin-1 (ET-1) on hemodynamics and cardiac contractility were compared with the responses to angiotensin I (AI) and phenylephrine (PE) in Milan normotensive rats. Intravenous (i.v.) injection of ET-1 (0.8 nmol/kg) initially decreased mean blood pressure (MBP), total peripheral resistance (TPR), and dP/dt (-28 +/- 2, -34.8 +/- 3.7, and -9.4 +/- 1.3%, p less than 0.01, respectively), and increased heart rate (HR), cardiac output (CO), and the velocity of myocardial anterior wall shortening (dL/dt) (11.8 +/- 2.1, 10.4 +/- 2.9, and 28.3 +/- 8.3% p less than 0.05, respectively). These effects were followed by a sustained increase in MBP and TPR and a decrease in CO. As compared with AI (0.25 nmol/kg) and PE (35 nmol/kg), which produced a similar degree of increase in TPR, the reduction in CO induced by ET-1 was more prominent (-25 +/- 2 by ET-1 vs. -14 +/- 2 by AI and -14 +/- 3% by PE, p less than 0.05, respectively). Moreover, ET-1 induced a significant decrease in dP/dt, shortening fraction (SF), and dL/dt (-6.1 +/- 1.6, -35.0 +/- 3.8, and -38.6 +/- 5.5%, p less than 0.01, respectively), whereas these indexes of left ventricle performance were not affected by either AI or PE. Furthermore, the reduction in SF induced by ET-1 was mainly due to the decrease in myocardial diastolic segment length, suggesting reduction in diastolic filling volume.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1711636pubmed:languageenglld:pubmed
pubmed-article:1711636pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711636pubmed:citationSubsetIMlld:pubmed
pubmed-article:1711636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711636pubmed:statusMEDLINElld:pubmed
pubmed-article:1711636pubmed:monthAprlld:pubmed
pubmed-article:1711636pubmed:issn0160-2446lld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:RossiRRlld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:BianchiGGlld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:MichelettiRRlld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:VeitSSlld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:EnglishEElld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:MadedduPPlld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:GiacaloneGGlld:pubmed
pubmed-article:1711636pubmed:authorpubmed-author:BenattiPPlld:pubmed
pubmed-article:1711636pubmed:issnTypePrintlld:pubmed
pubmed-article:1711636pubmed:volume17lld:pubmed
pubmed-article:1711636pubmed:ownerNLMlld:pubmed
pubmed-article:1711636pubmed:authorsCompleteYlld:pubmed
pubmed-article:1711636pubmed:pagination662-9lld:pubmed
pubmed-article:1711636pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:meshHeadingpubmed-meshheading:1711636-...lld:pubmed
pubmed-article:1711636pubmed:year1991lld:pubmed
pubmed-article:1711636pubmed:articleTitleEffects of intravenous endothelin on hemodynamics and cardiac contractility in conscious Milan normotensive rats.lld:pubmed
pubmed-article:1711636pubmed:affiliationPrassis Research Institute, Milan, Italy.lld:pubmed
pubmed-article:1711636pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711636lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711636lld:pubmed